The Hill's Rising podcast features a discussion regarding the efficacy of Ivermectin against COVID-19 in South Africa and Asia compared to the United States. One participant suggests the drug's success in those regions is due to its ability to treat parasitic worms, thereby improving the overall health of patients fighting the virus. The segment notes that while Ivermectin won a Nobel Prize for treating river blindness, its role as a primary COVID-19 treatment remains a subject of intense debate between mainstream and fringe media sources.
